Study details
Enrolling now
LY900040 Pediatric Obesity Trial
Eli Lilly and Company
NCT IDNCT06672549ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
125
Study length
about 2.4 years
Ages
6–17
Locations
16 sites in CA, CT, GA +10
What this study is about
Researchers are testing a medication called orforglipron to help children with obesity manage their weight. The trial will last for 863 days and involve approximately 125 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Orforglipron
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Endocrinology